Koenen Andrea, Babendreyer Aaron, Schumacher Julian, Pasqualon Tobias, Schwarz Nicole, Seifert Anke, Deupi Xavier, Ludwig Andreas, Dreymueller Daniela
Institute of Pharmacology and Toxicology, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Institute of Molecular and Cellular Anatomy, Medical Faculty, RWTH Aachen University, Aachen, Germany.
PLoS One. 2017 Mar 7;12(3):e0173486. doi: 10.1371/journal.pone.0173486. eCollection 2017.
The CXC-chemokine receptor 6 (CXCR6) is a class A GTP-binding protein-coupled receptor (GPCRs) that mediates adhesion of leukocytes by interacting with the transmembrane cell surface-expressed chemokine ligand 16 (CXCL16), and also regulates leukocyte migration by interacting with the soluble shed variant of CXCL16. In contrast to virtually all other chemokine receptors with chemotactic activity, CXCR6 carries a DRF motif instead of the typical DRY motif as a key element in receptor activation and G protein coupling. In this work, modeling analyses revealed that the phenylalanine F3.51 in CXCR6 might have impact on intramolecular interactions including hydrogen bonds by this possibly changing receptor function. Initial investigations with embryonic kidney HEK293 cells and further studies with monocytic THP-1 cells showed that mutation of DRF into DRY does not influence ligand binding, receptor internalization, receptor recycling, and protein kinase B (AKT) signaling. Adhesion was slightly decreased in a time-dependent manner. However, CXCL16-induced calcium signaling and migration were increased. Vice versa, when the DRY motif of the related receptor CX3CR1 was mutated into DRF the migratory response towards CX3CL1 was diminished, indicating that the presence of a DRF motif generally impairs chemotaxis in chemokine receptors. Transmembrane and soluble CXCL16 play divergent roles in homeostasis, inflammation, and cancer, which can be beneficial or detrimental. Therefore, the DRF motif of CXCR6 may display a receptor adaptation allowing adhesion and cell retention by transmembrane CXCL16 but reducing the chemotactic response to soluble CXCL16. This adaptation may avoid permanent or uncontrolled recruitment of inflammatory cells as well as cancer metastasis.
CXC趋化因子受体6(CXCR6)是一种A类鸟苷酸结合蛋白偶联受体(GPCR),它通过与跨膜细胞表面表达的趋化因子配体16(CXCL16)相互作用介导白细胞黏附,还通过与CXCL16的可溶性脱落变体相互作用调节白细胞迁移。与几乎所有其他具有趋化活性的趋化因子受体不同,CXCR6带有DRF基序而非典型的DRY基序,作为受体激活和G蛋白偶联的关键元件。在这项研究中,建模分析表明,CXCR6中的苯丙氨酸F3.51可能通过改变受体功能影响包括氢键在内的分子内相互作用。对胚胎肾HEK293细胞的初步研究以及对单核细胞THP-1细胞的进一步研究表明,将DRF突变为DRY不影响配体结合、受体内化、受体再循环和蛋白激酶B(AKT)信号传导。黏附以时间依赖性方式略有降低。然而,CXCL16诱导的钙信号传导和迁移增加。反之,当相关受体CX3CR1的DRY基序突变为DRF时,对CX3CL1的迁移反应减弱,表明DRF基序的存在通常会损害趋化因子受体的趋化性。跨膜和可溶性CXCL16在稳态、炎症和癌症中发挥不同作用,可能有益也可能有害。因此,CXCR6的DRF基序可能显示出一种受体适应性,允许通过跨膜CXCL16实现黏附和细胞滞留,但降低对可溶性CXCL16的趋化反应。这种适应性可能避免炎症细胞的永久性或不受控制的募集以及癌症转移。